> top > docs > PMC:7784786 > spans > 6392-7094 > annotations

PMC:7784786 / 6392-7094 JSONTXT

Annnotations TAB JSON ListView MergeView

LitCovid-PubTator

Id Subject Object Predicate Lexical cue tao:has_database_id
227 49-59 Chemical denotes itolizumab MESH:C000597346
234 82-92 Chemical denotes itolizumab MESH:C000597346
235 228-238 Chemical denotes itolizumab MESH:C000597346
236 451-461 Chemical denotes itolizumab MESH:C000597346
237 578-588 Chemical denotes itolizumab MESH:C000597346
238 200-216 Disease denotes pleural effusion MESH:D010996
239 403-419 Disease denotes pleural effusion MESH:D010996

LitCovid-PD-HP

Id Subject Object Predicate Lexical cue hp_id
T17 200-216 Phenotype denotes pleural effusion http://purl.obolibrary.org/obo/HP_0002202
T18 403-419 Phenotype denotes pleural effusion http://purl.obolibrary.org/obo/HP_0002202

LitCovid-sentences

Id Subject Object Predicate Lexical cue
T58 0-60 Sentence denotes Radiological images before and after one dose of itolizumab.
T59 61-188 Sentence denotes Patient 1 (A) Before itolizumab (D0): diffuse Interstitial-alveolar infiltrate in both lung fields, predominantly in the bases.
T60 189-392 Sentence denotes Minor left pleural effusion. (B) After itolizumab (48 h): radiological improvement with decreased diffuse infiltrate and radio-opacity at the top of both lungs and in both lung bases, in less proportion.
T61 393-429 Sentence denotes The minor pleural effusion persists.
T62 430-702 Sentence denotes Patient 3 (C) Before itolizumab (D0): alveolar interstitial inflammatory infiltrate in both lung fields, predominantly on the right side. (D) After itolizumab (48 h): radiological improvement with significant decrease of the alveolar interstitial infiltrate of both lungs.